The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill.
Recent Posts
- Hassett Fed chair odds fall, Warsh chances surge on Kalshi after Trump comments
- Trump says Kevin Warsh is at top of Fed chair candidate list, president should be consulted on rates
- Coinbase to soon unveil prediction markets powered by Kalshi, source says
- There’s still time to maximize the 0% capital gains bracket for 2025. Here’s what to know
- Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC; pot stocks surge